No Data
No Data
Izutsuya and other [buying demand for next week]
[Buy demand next week (table)] Code; Stock name; Stock price impact; Buy demand; Credit ratio; Closing price; Change from the previous day <7872> ; Esteel; 390%; 18,700; 0.60; 627; 3 <7510> ; Takebishi; 314%; 113,000; 0.01; 2,381; 34 <4934> ; P Anti-Age; 303%; 27,300; 1.89; 726; -9 <5031> ; Moi; 292%; 61,300; 2.16; 266; -4 <5262> ; Nihyume;
The TOPIX Global Market 250 index fell, with the recoil of the previous day's sharp rise before the three-day weekend.
The Tokyo Stock Exchange Growth Market Index is 823.52, down 10.21, with a volume of 0.107 billion 70.09 million shares and a transaction value of 116.5 billion yen. The Tokyo Stock Exchange Growth Market 250 Index is 644.48, down 8.79, with a volume of 0.109 billion 9.93 million shares and a transaction value of 95.9 billion yen. Today's growth market, both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index, fell. The number of advancing stocks is 197, the number of declining stocks is 352, and unchanged stocks is 30. The U.S. stock market on the 12th continued to rise. The Dow Jones Industrial Average rose 235.06 points (+0.
Tobu Construction Corp. 1Q operating profit increased by 72.5% to 5.168 billion yen.
Tobishima Corporation (1766) announced that the first quarter performance for the April 2025 fiscal year showed a revenue increase of 8.3% year-on-year to 89.012 billion yen, and an operating profit increase of 72.5% to 5.168 billion yen. In the real estate rental business, the increase in the number of managed properties led to an increase in revenue from tenant rents and management fees due to the sublease management system (bulk lease system), resulting in an increase in revenue compared to the same period last year. In the construction business, the order backlog for the previous consolidated fiscal year increased.
Premier Anti-Aging Co. Faces Sales Decline but Maintains Solid Equity
Premier Anti-Aging Resets Goals Amid Market Challenges
Premier Anti-Aging Outperforms Financial Forecasts
No Data
No Data